Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-(benzyloxy)-7-cyanonaphthalene-2-carboxylic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

178877-05-9

Post Buying Request

178877-05-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

178877-05-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 178877-05-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,8,8,7 and 7 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 178877-05:
(8*1)+(7*7)+(6*8)+(5*8)+(4*7)+(3*7)+(2*0)+(1*5)=199
199 % 10 = 9
So 178877-05-9 is a valid CAS Registry Number.

178877-05-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(Benzyloxy)-7-cyano-2-naphthoic acid

1.2 Other means of identification

Product number -
Other names 4-benzyloxy-6-fluoroindole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:178877-05-9 SDS

178877-05-9Relevant articles and documents

Synthesis of fluorescence-labelled glycosidic prodrugs based on the cytotoxic antibiotic duocarmycin

Tietze, Lutz F.,Behrendt, Frank,Major, Felix,Krewer, Birgit,Von Hof, J. Marian

supporting information; experimental part, p. 6909 - 6921 (2011/02/23)

The synthesis of the glycosidic prodrugs (1S)-30a, (1S,10R)-30b and (1S,10R)-32 labelled with different fluorescence dyes at different positions at the aromatic A-ring in 2 is described; the compounds are structurally based on the cytotoxic antibiotic duocarmycin SA. For binding, the amino compounds (1S)-3a and (1S,10R)-3b were treated with the commercially available succinimides of the dyes 5-SFX (29) and D10162 (31), respectively. Fluorescence-labelled compounds can be used for verification of interaction with cellular targets on the molecular level by use of confocal laser scanning microscopy for cell cultures and the Explore-Optics instrument (GE) for mice. The described fluorescence-labelled glycosidic prodrugs based on the cytotoxic antibiotic duocarmycine SA have high potential for selective treatment of cancer. Copyright

Analogs of CC-1065 and the duocarmycins

-

, (2008/06/13)

PCT No. PCT/US97/09076 Sec. 371 Date Sep. 7, 1999 Sec. 102(e) Date Sep. 7, 1999 PCT Filed May 30, 1997 PCT Pub. No. WO97/45411 PCT Pub. Date Dec. 4, 1997Analogs of antitumor antibiotics CC-1065 and the duocarmycins are synthesized which possess systematic

Synthesis, chemical properties, and preliminary evaluation of substituted CBI analogs of CC-1065 and the duocarmycins incorporating the 7-cyano-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one alkylation subunit: Hammett quantitation of the magnitude of electronic effects on functional reactivity

Boger, Dale L.,Han, Nianhe,Tarby, Christine M.,Boyce, Christopher W.,Cai, Hui,Jin, Qing,Kitos, Paul A.

, p. 4894 - 4912 (2007/10/03)

The synthesis of 7-cyano-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (CCBI), a substituted CBI derivative bearing a C7 cyano group, is described in efforts that establish the magnitude of potential electronic effects on the functional reactivity of the agents. The CCBI alkylation subunit was prepared by a modified Stobbe condensation/Friedel-Crafts acylation for generation of the appropriately functionalized naphthalene precursors followed by 5-exo-trig aryl radical-alkene cyclization for synthesis of the 1,2-dihydro-3H-benz[e]indole skeleton and final Ar-3′ alkylation for introduction of the activated cyclopropane. The most concise approach provided the CCBI subunit and its immediate precursor in 14-15 steps in superb overall conversions (15-20percent). Resolution of an immediate CCBI precursor and its incorporation into both enantiomers of 34-39, analogs of CC-1065 and the duocarmycins, are detailed. A study of the solvolysis reactivity and regioselectivity of N-BOC-CCBI (25) revealed that introduction of the C7 nitrile slowed the rate of solvolysis but only to a surprisingly small extent. Classical Hammett quantitation of the effect provided a remarkably small ρ (-0.3), indicating an exceptionally small C7 substituent electronic effect on functional reactivity. Additional kinetic studies of acid-catalyzed nucleophilic addition proved inconsistent with C4 carbonyl protonation as the slow and rate-determining step but consistent with a mechanism in which protonation is rapid and reversible followed by slow and rate-determining nucleophilic addition to the cyclopropane requiring both the presence and assistance of a nucleophile (SN2 mechanism). No doubt this contributes to the DNA alkylation selectivity of this class of agents and suggests that the positioning of an accessible nucleophile (adenine N3) and not C4 carbonyl protonation is the rate-determining step controlling the sequence selectivity of the DNA alkylation reaction. This small electronic effect on the solvolysis rate had no impact on the solvolysis regioselectivity, and stereoelectronically-controlled nucleophilic addition to the least substituted carbon of the activated cyclopropane was observed exclusively. Consistent with past studies, a direct relationship between solvolysis stability and cytotoxic potency was observed with the CCBI-derived agents providing the most potent analogs in the CBI series, and these observations were related to the predictable Hammett substituent effects. For the natural enantiomers, this unusually small electronic effect on functional reactivity had no perceptible effect on their DNA alkylation selectivity. Similar effects of the C7 cyano substituent on the unnatural enantiomers were observed, and they proved to be 4-10× more effective than the corresponding CBI-based unnatural enantiomers and 4-70× less potent than the CCBI natural enantiomers.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 178877-05-9